Tech Company Financing Transactions

Lumena Pharmaceuticals Funding Round

On 5/8/2013, Lumena Pharmaceuticals raised $8 million in Series A funding from Alta Partners, Pappas Ventures and RiverVest Venture Partners.

Transaction Overview

Announced On
5/8/2013
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Investors

Alta Partners (Robert Alexander)

Pappas Ventures (Michael Grey)

RiverVest Venture Partners (John McKearn)

Proceeds Purpose
Lumena will primarily use the funding to advance the clinical development of LUM001, the company's lead product candidate for the treatment of cholestatic liver disease in pediatric and adult patients.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12531 High Bluff Drive 110
San Diego, CA 92130
USA
Email Address
Overview
Lumena Pharmaceuticals is focused on advancing treatments in metabolic diseases that have high unmet clinical needs.
Profile
Lumena Pharmaceuticals  LinkedIn Company Profile
Social Media
Lumena Pharmaceuticals  Company Twitter Account
Company News
Lumena Pharmaceuticals  News
Facebook
Lumena Pharmaceuticals  on Facebook
YouTube
Lumena Pharmaceuticals  on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Grey
  Michael Grey LinkedIn Profile  Michael Grey Twitter Account  Michael Grey News  Michael Grey on Facebook
Chief Financial Officer
Alana McNulty
  Alana McNulty LinkedIn Profile  Alana McNulty Twitter Account  Alana McNulty News  Alana McNulty on Facebook
Chief Medical Officer
Alejandro Dorenbaum
  Alejandro Dorenbaum LinkedIn Profile  Alejandro Dorenbaum Twitter Account  Alejandro Dorenbaum News  Alejandro Dorenbaum on Facebook
VP - Operations
Ciara Kennedy
  Ciara Kennedy LinkedIn Profile  Ciara Kennedy Twitter Account  Ciara Kennedy News  Ciara Kennedy on Facebook
VP - R & D
Bradley Keller
  Bradley Keller LinkedIn Profile  Bradley Keller Twitter Account  Bradley Keller News  Bradley Keller on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/8/2013: Cover venture capital transaction
Next: 5/8/2013: Solaborate venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary